Publications where Immunitrack's FcRn Reagents were used
Kræmmer Schelde et al., A new class of recombinant human albumin with multiple surface thiols exhibit stable conjugation, and enhanced FcRn binding and blood circulation. J Biol Chem. 2019 Mar 8;294(10):3735-3743
Grevys A et al., A human endothelial cell based recycling assay for screening of FcRn. Nat Commun. 2018 Feb 12;9(1):621.
Ulrichts et al., Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. J Clin Invest. 2018 Oct 1; 128(10): 4372–4386.
Burkrinski et al., Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life. Biochemistry. 2017 Sep 12;56(36):4860-4870
Culina, S. et al. Materno-fetal transfer of preproinsulin through the neonatal Fc receptor prevents autoimmune diabetes.
Diabetes. 2015 64(10):3532-42.
Gupta, N. et al. Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance.
Sci Transl Med. 2015 7(275):275ra21.
Wozniak-Knopp, G. et al. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds. PLoS One. 2012 7(1):e30083.
Andersen, J.T. et al. Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. FEBS J. 2008 275(16):4097-110.
Andersen, J.T. et al. A strategy for neonatal Fc receptor with mutation of two unpaired cysteine residues. Bacterial production of a soluble functional human neonatal Fc receptor. J Immunol Methods. 2008 331(1-2):39-49.